researchtopractice
PI3K Delta Inhibitor Idelalisib - Research To Practice
Feb 2, 2013 ... refractory FL. • Assess the benefits and risks of novel therapeutic approaches — PI3 kinase inhibitors, Btk inhibitors and chimeric antigen receptor T ... Gilead Sciences Inc, Mundipharma International Limited, Onyx .... PI3 kinase delta inhibitor combined with R and/or bendamustine (B) in 52 patients with.
researchtopractice
-
Address
-
Tel
-
researchtopractice.com
Website
researchtopractice 's social
Update The Recent Import And Export Records
World Trade History Data
|
Date
|
Product Description
|
Supplier
|
Money
|
Quantity
|
Weight
|
|---|
Creating Contacts Get 5 Years of Import and Export Data for this Company
Get Key Contact Information
Contacts
FAQs researchtopractice
researchtopractice's website is?
researchtopractice's website is researchtopractice.com
